Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reactive oxygen species (ROS) generation and oxidative stress machinery refers to the integrated system of enzymes, metabolic pathways, and antioxidant defenses that regulate the cellular redox state. Primary sources of ROS include the mitochondrial electron transport chain and the NADPH oxidase (NOX) family of enzymes, which produce superoxide and hydrogen peroxide as byproducts or signaling molecules (Sies et al., 2017, Nature Reviews Molecular Cell Biology). To maintain homeostasis, the cell employs an antioxidant machinery consisting of enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase, largely regulated by the Nrf2 (Nuclear factor erythroid 2-related factor 2) transcription factor (Hayes & Dinkova-Kostova, 2014, Trends in Biochemical Sciences). Chronic disruption of this balance leads to oxidative stress, a state characterized by oxidative damage to lipids, proteins, and DNA, which is a hallmark of aging, neurodegeneration, and cardiovascular disease (Betteridge, 2000, Metabolism). Therapeutic strategies targeting this machinery include direct ROS scavengers, mitochondrial-targeted antioxidants, and Nrf2 activators like dimethyl fumarate, which enhance the endogenous antioxidant response (Liby & Sporn, 2012, Nature Reviews Cancer). However, targeting this system is challenging because low levels of ROS are essential for physiological processes like mitogen signaling and pathogen defense, leading to potential safety concerns regarding the antioxidant paradox (Halliwell, 2011, Free Radical Research).
ROS scavenging, Nrf2 activation, NADPH oxidase inhibition, Mitochondrial protection, Upregulation of antioxidant enzymes
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation and oxidative stress machinery (ROS/Oxidative Stress Machinery).